FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Jubilant Cadista Pharmaceuticals Olanzapine Orally Disintegrating Tablets Recall

Olanzapine Orally Disintegrating Tablets, 5 mg, 30 count (3x10 unit dose) blister pack,…

Jubilant Cadista Pharmaceuticals, Inc. · Salisbury, MD

Risk level
Class III
Reported by FDA
Nov 11, 2020
Recall ID
D-0066-2021
Check your lot numberHow we source this data

Summary

Jubilant Cadista Pharmaceuticals recalled Olanzapine Orally Disintegrating Tablets starting Oct 26, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0066-2021 on Nov 11, 2020. Reason: Subpotent. Status: Terminated.

Why it was recalled

Subpotent

Product description

Olanzapine Orally Disintegrating Tablets, 5 mg, 30 count (3x10 unit dose) blister pack, Rx only, Manufactured by: Jubilant Generics, Ltd., Roorkee, India, Marketed by: Jubilant Cardista Pharmaceuticals, Inc., Salisbury, MD NDC 59746-0306-32

Lot numbers, UPCs & expiration codes

Lot # AE119001A, exp. date 01/2021

Where it was sold

Product was distributed nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0066-2021
Classification
Class III
Status
Terminated
Recall initiated
Oct 26, 2020
FDA report date
Nov 11, 2020
Quantity
23,616 blister packs
Recall type
Voluntary: Firm initiated
Recalling firm
Jubilant Cadista Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0066-2021, exactly as published.

Show all FDA fields
City
Salisbury
State
MD
Status
Terminated
Country
United States
Event ID
86658
Address
207 Kiley Dr
Code information
Lot # AE119001A, exp. date 01/2021
Postal code
21801-2249
Report date
Nov 11, 2020
Product type
Drugs
Recall number
D-0066-2021
Classification
Class III
Recalling firm
Jubilant Cadista Pharmaceuticals, Inc.
Product quantity
23,616 blister packs
Termination date
Aug 11, 2021
Reason for recall
Subpotent
Voluntary / mandated
Voluntary: Firm initiated
Product description
Olanzapine Orally Disintegrating Tablets, 5 mg, 30 count (3x10 unit dose) blister pack, Rx only, Manufactured by: Jubilant Generics, Ltd., Roorkee, India, Marketed by: Jubilant Cardista Pharmaceuticals, Inc., Salisbury, MD NDC 59746-0306-32
Distribution pattern
Product was distributed nationwide
Recall initiation date
Oct 26, 2020
Initial firm notification
Letter
Center classification date
Nov 5, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0066-2021, published Nov 11, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls